JP2021500393A - 植物ゾウゲ抽出物(ファイテレファス属種(Phytelephas sp.))の化粧的使用 - Google Patents
植物ゾウゲ抽出物(ファイテレファス属種(Phytelephas sp.))の化粧的使用 Download PDFInfo
- Publication number
- JP2021500393A JP2021500393A JP2020523712A JP2020523712A JP2021500393A JP 2021500393 A JP2021500393 A JP 2021500393A JP 2020523712 A JP2020523712 A JP 2020523712A JP 2020523712 A JP2020523712 A JP 2020523712A JP 2021500393 A JP2021500393 A JP 2021500393A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- extract
- composition
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 71
- 239000002537 cosmetic Substances 0.000 title claims abstract description 56
- 241000406668 Loxodonta cyclotis Species 0.000 title claims abstract description 54
- 241000196324 Embryophyta Species 0.000 title claims description 53
- 241000202428 Phytelephas Species 0.000 title claims description 6
- 239000000203 mixture Substances 0.000 claims abstract description 79
- 238000000034 method Methods 0.000 claims abstract description 14
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 10
- 230000036571 hydration Effects 0.000 claims abstract description 3
- 238000006703 hydration reaction Methods 0.000 claims abstract description 3
- 210000003491 skin Anatomy 0.000 claims description 56
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 26
- 210000002510 keratinocyte Anatomy 0.000 claims description 20
- 230000009471 action Effects 0.000 claims description 15
- 229920001282 polysaccharide Polymers 0.000 claims description 13
- 239000005017 polysaccharide Substances 0.000 claims description 13
- 150000004676 glycans Chemical class 0.000 claims description 12
- 230000009467 reduction Effects 0.000 claims description 11
- 210000002752 melanocyte Anatomy 0.000 claims description 10
- 208000012641 Pigmentation disease Diseases 0.000 claims description 8
- 230000008099 melanin synthesis Effects 0.000 claims description 8
- 230000006872 improvement Effects 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 229920000057 Mannan Polymers 0.000 claims description 6
- 241000894007 species Species 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 5
- 210000004400 mucous membrane Anatomy 0.000 claims description 5
- 230000036560 skin regeneration Effects 0.000 claims description 5
- 241000202427 Phytelephas aequatorialis Species 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 230000004069 differentiation Effects 0.000 claims description 4
- 238000009826 distribution Methods 0.000 claims description 4
- 230000005764 inhibitory process Effects 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 241001019674 Phytelephas schottii Species 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 3
- 235000007173 Abies balsamea Nutrition 0.000 claims description 2
- 241000592335 Agathis australis Species 0.000 claims description 2
- 244000018716 Impatiens biflora Species 0.000 claims description 2
- 240000003155 Passiflora seemannii Species 0.000 claims description 2
- 241001019672 Phytelephas tenuicaulis Species 0.000 claims description 2
- 235000014121 butter Nutrition 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- -1 impregnated pads Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 230000037393 skin firmness Effects 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 244000208789 Phytelephas macrocarpa Species 0.000 claims 2
- 241000024138 Ctenophryne aequatorialis Species 0.000 claims 1
- 235000010633 broth Nutrition 0.000 claims 1
- 230000037373 wrinkle formation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 26
- 210000004027 cell Anatomy 0.000 description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 11
- 239000002904 solvent Substances 0.000 description 9
- 108010014258 Elastin Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 210000004207 dermis Anatomy 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 239000006286 aqueous extract Substances 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 102100033167 Elastin Human genes 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000001569 carbon dioxide Substances 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- 241000233788 Arecaceae Species 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 108060008539 Transglutaminase Proteins 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 238000009499 grossing Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 102000003601 transglutaminase Human genes 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- 241001133760 Acoelorraphe Species 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000283080 Proboscidea <mammal> Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 238000004299 exfoliation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 210000002780 melanosome Anatomy 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241000346081 Kerriodoxa elegans Species 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 244000179684 Passiflora quadrangularis Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 230000005496 eutectics Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940100573 methylpropanediol Drugs 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 210000000282 nail Anatomy 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 229940067107 phenylethyl alcohol Drugs 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000283094 Elephas Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 description 1
- 101000620359 Homo sapiens Melanocyte protein PMEL Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 244000165077 Insulata Species 0.000 description 1
- 235000010702 Insulata Nutrition 0.000 description 1
- 102100032816 Integrin alpha-6 Human genes 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 102100022430 Melanocyte protein PMEL Human genes 0.000 description 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 1
- 101710200814 Melanotropin alpha Proteins 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 244000151448 Podochilus tenuis Species 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 230000007073 chemical hydrolysis Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 description 1
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 description 1
- 229940093767 glabridin Drugs 0.000 description 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000005128 keratinized epithelium Anatomy 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 238000009283 thermal hydrolysis Methods 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
使用、さらには植物ゾウゲ抽出物を含む化粧組成物又は皮膚科学的組成物、並びにこの組成物が関与する方法及びデバイスに関する。
− P.マクロカルパ Ruiz & Pav(P. macrocarpa Ruiz & Pav)
− P.アエクアトリアリス スプルース(P. aequatorialis Spruce)
− P.テヌイカウリス(バーフォド)A.ヘンドル(P. tenuicaulis (Barfod) A. H
endl)
− P.ショッティ H.ウェンドル(P. Schottii H. Wendl)
− P.セエマンニイ O.F.クック(P. seemannii O. F. Cook)
[4]))。
1 − 植物ゾウゲ(ファイテレファス属種)の種子を構成するポリサッカリドが、植物ゾウゲ種子(ファイテレファス属種)の微細胚乳粉末の形態で、亜臨界状態の水及び超臨界状態の二酸化炭素と共にオートクレーブ中で混合される熱加水分解の工程;
2 − 10℃〜200℃の温度で二酸化炭素を前記オートクレーブに注入して、前記オートクレーブ中の圧力を30バール〜50バールに到達させることから成る工程;
3 − 次に、110℃〜200℃の温度で二酸化炭素を前記オートクレーブにポンプによって注入して、100バール〜250バールの圧力への前記ポリサッカリドの圧力上昇を誘導することから成る工程;
4 − 部分加水分解されたポリサッカリドを、水性抽出物の形態で回収する工程;
5 − 部分加水分解されたポリサッカリドを含有する植物ゾウゲ種子(ファイテレファス属種)の水性抽出物を滅菌ろ過する工程;
6 − 水性抽出物の保存及び保管を可能とするために、保存剤が添加される最終工程。
3−プロパンジオール、Microcare(登録商標)(ソルビン酸カリウム及び安息香酸ナトリウムの混合物)から選択されてよいがこのリストに限定されない保存剤が添加された水性液体の形態で維持されてよい。
充分である。
以下の例では、植物ゾウゲ抽出物(ファイテレファス属種)を、以下のように、仏特許第1656186号([6])に記載のポリサッカリドの部分解重合の方法に従って調製した。
1 − 植物ゾウゲ種子(ファイテレファス属種)由来の微細胚乳粉末、商品名:LIPO VI(ファイテレファスアエカトラリス(Phytelephas aequatoralis))、Vantage Specialty Chemicals社から市販、を、オートクレーブ中、亜臨界状態の水及び超臨界状態の二酸化炭素と、1%の比(粉末/溶媒、重量/重量)で接触させる。
2 − 150℃の温度で二酸化炭素を前記オートクレーブに注入して、前記オートクレーブ中の圧力を30バール〜50バールに到達させる。
3 − 次に、150℃の温度で二酸化炭素を前記オートクレーブにポンプによって5時間にわたって注入して、100バールの圧力への前記ポリサッカリドの圧力上昇を誘導することから成る工程。
4 − 大気温度及び圧力の条件に戻した後、マンナンのオリゴマーに相当する部分加水分解されたポリサッカリドを、水性抽出物の形態で回収する。
5 − 部分加水分解されたポリサッカリドを含有する植物ゾウゲ種子(ファイテレファス属種)の水性抽出物を滅菌ろ過する工程を適用する。
トロポエラスチンの合成を、増殖培地中で培養し、続いて96ウェルプレートで基礎培地中(DMEM、2mMのL−グルタミン及び1%のウシ胎仔血清含有)、植物ゾウゲ抽出物(0.2%又は1%)で72時間処理した線維芽細胞の単層培養物で調べる。インキュベーションの終了後、細胞叢を固定し、次にトロポエラスチンに対する一次抗体で標識し、それを、蛍光二次抗体(GAR−Alexa 488)で明らかにする。次に、トロポエラスチンの標識によって誘導された蛍光の強度を定量し、核の数を基準とさせる(Hoechst 33258染色)。ポジティブ内部標準は、TGF−βである(10ng/ml)。以下の表1に示す計算は、値を基礎培地の値と比較することによって行ったものである(単位は%)。
この実験は、腹壁形成術から得た正常なヒトケラチノサイト及び正常なヒトメラノサイトに対して行い、それらを適切な培養条件で、すなわち、ケラチノサイト−SFM培地及び添加した培地254の混合物(4:1の比)中、37℃の温度及び5%CO2を含む飽和湿度雰囲気下で、単層に播種した。細胞を、植物ゾウゲ抽出物により、48時間にわたって、次に72時間にわたって、0.003%で2回処理した(表2を参照)。次に、細胞を回収し、メラニンの移動を、ケラチノサイトをCD49f抗体(Invitrogen)で、及びメラノソームをメラノソームのタンパク質の特異的抗体(Pmel17)で同時標識することによって評価する。この同時標識を、フローサイトメトリー分析と組み合わせることで、有効にケラチノサイトへ移動したメラノソームを特異的に定量することが可能となる。
この実験は、FGF bullet kit(Lonza)、カルシウム、PMA(ホルボールミリステートアセテート)、アルファ−MSH(メラノサイト刺激ホルモン)、及びFCS(ウシ胎仔血清)を添加したKBM−Gold培地で培養したメラノサイト細胞株S91に対して行った。細胞を、メラニン合成を活性化するための1mMのL−チロシン、及び5・10−2%又は5・10−3%の植物ゾウゲ抽出物で72時間処理する(表3)。並行して、メラニン合成の阻害のコントロールとして、細胞を、5μg/mlのリポ酸で処理する。メラニンを、1Nソーダ中に60℃で30分間溶解することによって分析し、次に405nmでのODを読み取ることで測定する。
ことができる。これらの結果から、抽出物は、5・10−2%でシミをなくす効果を有す
ることが示される。
この実験は、腹壁形成術から得た正常なヒト表皮ケラチノサイトに対して行い、それらを適切な培養条件で、すなわち、ケラチノサイト−SFM培地中、37℃の温度、5%CO2の飽和湿度雰囲気下で、単層に播種した。細胞を、植物ゾウゲ抽出物により、96時間にわたって、1%で処理した(表4)。次に、トランスグルタミナーゼ活性を、カゼインとの共有結合によるトリチウム標識したプトレシンの取り込みを、続いてのカゼインの析出によって測定することで特定する。
1.Nature, Scientific Reports 5, (2015), A Sustainable Substitute for Ivory: the Jarina Seed from the Amazon, Chu et al.
2.Des graines et des hommes (Seeds and men), Romain Dufayard, Edition Sang de la Terre, Paris, 2010.
3. Field guide to the palms of the Americas, A.Henderson et al., 1997, Princeton University Press.
4.Annals of Applied Biology (2014), 164, 257-269 Productivity and management
of Phytelephas aequatorialis (Arecaceae) in Ecuador.
5.Handbook of Nuts, James A.Duke, CRC Press, London, 2001.
6.仏特許第1656186号
7.仏特許第3017292号
Claims (14)
- 皮膚の色及び/又は顔色の均質性の向上、皮膚の色素斑の低減、皮膚のツヤの向上、皮膚の再生の向上、皮膚のタルミの低減、皮膚のハリの喪失の低減、シワの形成の低減、並びに皮膚、その付属器、及び/又は粘膜の水分補給、から選択される少なくとも1つの作用のための、植物ゾウゲ抽出物(ファイテレファス属種(Phytelephas sp.))の化粧的
使用。 - 前記顔色の均質性の向上及び/又は色素斑の低減の前記作用が、ケラチノサイト中のメラニンの分布を、メラノサイトから前記ケラチノサイトへのメラニンの移動を刺激することによって改善することである、請求項1に記載の化粧的使用。
- 前記顔色の均質性の向上及び皮膚の色素斑の低減の前記作用が、メラニン合成の阻害である、請求項1又は2に記載の化粧的使用。
- ツヤの向上又は前記顔色の均一性の向上の前記作用が、前記ケラチノサイトの分化の刺激の作用である、請求項1〜3のいずれか一項に記載の化粧的使用。
- 前記抽出物が、植物ゾウゲ胚乳粉末の部分加水分解に由来する、請求項1〜4のいずれか一項に記載の化粧的使用。
- 前記抽出物が、部分加水分解されたポリサッカリドの混合物を含有する、請求項1〜5のいずれか一項に記載の化粧的使用。
- 前記抽出物が、重合度が1〜30の範囲内であるマンナンのオリゴマーを含有する、請求項1〜6のいずれか一項に記載の化粧的使用。
- P.マクロカルパ Ruiz & Pav(P. macrocarpa Ruiz & Pav)、P.アエクアトリアリス スプルース(P. aequatorialis Spruce)、P.テヌイカウリス(バーフ
ォド)A.ヘンドル(P. tenuicaulis (Barfod) A. Hendl)、P.ショッティ H.ウェンドル(P. Schottii H. Wendl)、及びP.セエマンニイ O.F.クック(P. seemannii O. F. Cook)から選択される植物ゾウゲの少なくとも1つの種に由来する、請求項1
〜7のいずれか一項に記載の化粧的使用。 - 植物ゾウゲ抽出物(ファイテレファス属種)、並びに化粧的及び/又は皮膚科学的に許容される媒体を含む化粧組成物又は皮膚科学組成物、特に、アンチエージング組成物であって、前記組成物は、前記組成物の総重量に対して0.00001〜5.0重量%の前記植物ゾウゲ抽出物を含む、組成物。
- 前記組成物が、軟膏、クリーム、オイル、乳剤、外用剤、粉末、含浸パッド、溶液、ゲル、しょう液、バルサム、バター、ローション、懸濁液、石鹸、又はエマルジョンから選択される形態である、請求項9に記載の組成物。
- ポット、ポンプボトル、ワイプ、マスク、経皮デバイス、パッチ、スプレーから選択される形態のデバイスであって、前記デバイスは、請求項9又は10のいずれか一項に記載の組成物を含む、デバイス。
- 皮膚の外観を改善するための化粧的方法であって、請求項9又は10のいずれか一項に記載の化粧組成物を前記皮膚に適用することを含む、化粧的方法。
- 対象の皮膚の外観を改善するための、請求項9又は10のいずれか一項に記載の化粧組成物又は皮膚科学的組成物の使用。
- 植物ゾウゲ抽出物と化粧的及び/又は皮膚科学的に許容される媒体との混合物を含む、請求項9又は10のいずれか一項に記載の化粧組成物又は皮膚科学的組成物を製造するための方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1760154 | 2017-10-27 | ||
FR1760154A FR3072878B1 (fr) | 2017-10-27 | 2017-10-27 | Utilisation cosmetique d'un extrait d'ivoire vegetal (phytelephas sp.) |
PCT/FR2018/052653 WO2019081859A1 (fr) | 2017-10-27 | 2018-10-25 | Utilisation cosmétique d'un extrait d'ivoire végétal (phytelephas sp.) |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021500393A true JP2021500393A (ja) | 2021-01-07 |
JP7289833B2 JP7289833B2 (ja) | 2023-06-12 |
Family
ID=61027893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020523712A Active JP7289833B2 (ja) | 2017-10-27 | 2018-10-25 | 植物ゾウゲ抽出物(ファイテレファス属種(Phytelephas sp.))の化粧的使用 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7289833B2 (ja) |
FR (1) | FR3072878B1 (ja) |
MX (1) | MX2020004257A (ja) |
WO (1) | WO2019081859A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180140536A1 (en) * | 2016-11-22 | 2018-05-24 | Epc Natural Products Co., Ltd. | Ivory nut powder and mannan from ivory nut |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5352631A (en) * | 1976-10-22 | 1978-05-13 | Kouichi Ogawa | Cosmetics |
JP2002284663A (ja) * | 2001-03-27 | 2002-10-03 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
JP2005110675A (ja) * | 2003-09-16 | 2005-04-28 | Meiji Univ | 低糖及び/又はオリゴ糖の製造方法、及び、機能性の低糖及び/又はオリゴ糖 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130195925A1 (en) * | 2011-11-03 | 2013-08-01 | Vaskin, Llc | Anti aging application and method for treating aging |
FR3017292B1 (fr) | 2014-02-11 | 2016-03-11 | Rocher Yves Biolog Vegetale | Base de formulation cosmetique d'origine naturelle ou vegetale et composition cosmetique |
-
2017
- 2017-10-27 FR FR1760154A patent/FR3072878B1/fr active Active
-
2018
- 2018-10-25 MX MX2020004257A patent/MX2020004257A/es unknown
- 2018-10-25 WO PCT/FR2018/052653 patent/WO2019081859A1/fr active Application Filing
- 2018-10-25 JP JP2020523712A patent/JP7289833B2/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5352631A (en) * | 1976-10-22 | 1978-05-13 | Kouichi Ogawa | Cosmetics |
JP2002284663A (ja) * | 2001-03-27 | 2002-10-03 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
JP2005110675A (ja) * | 2003-09-16 | 2005-04-28 | Meiji Univ | 低糖及び/又はオリゴ糖の製造方法、及び、機能性の低糖及び/又はオリゴ糖 |
Non-Patent Citations (3)
Title |
---|
"AGE-REFINING DAILY SCRUB", DATABASE GNPD [ONLINE], JPN5021002790, August 2017 (2017-08-01), pages 1 - 3, ISSN: 0005027779 * |
"DAWN TO DUSK FACIAL WASH", DATABASE GNPD [ONLINE], JPN5021002791, November 2016 (2016-11-01), pages 1 - 4, ISSN: 0005027780 * |
"SCRUB ME BODY EXFOLIATOR", DATABASE GNPD [ONLINE], JPN5021002792, June 2011 (2011-06-01), pages 1 - 4, ISSN: 0005027781 * |
Also Published As
Publication number | Publication date |
---|---|
WO2019081859A1 (fr) | 2019-05-02 |
FR3072878B1 (fr) | 2020-05-29 |
JP7289833B2 (ja) | 2023-06-12 |
MX2020004257A (es) | 2020-08-03 |
FR3072878A1 (fr) | 2019-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109937031B (zh) | 用于美容用途的袋鼠爪提取物 | |
JP6968534B2 (ja) | ピキア・アノマーラ及びチコリ根抽出物を含む局所用組成物 | |
CN107875067B (zh) | 皮肤细致组合物及其应用 | |
Nguyen et al. | Bioactive ingredients in Korean cosmeceuticals: Trends and research evidence | |
EP2961379B1 (fr) | Composition cosmétique contenant un extrait d'algue brune, un extrait de levure et d'acide ascorbique | |
CN110430865A (zh) | 包含桦褐孔菌提取物的化妆品组合物及其用途 | |
KR20210105880A (ko) | 시스투스 몬스펠리엔시스 추출물의 신규한 미용 및 피부과 용도 | |
FR3018191A1 (fr) | Utilisations cosmetiques de la swertiamarine | |
JPH11501325A (ja) | グリコサミノグリカン合成促進のための、特に化粧品におけるエリオボトリャ・ジャポニカ抽出物の使用 | |
CN113576975A (zh) | 一种易吸收的抗衰老组合物及其制备方法和应用 | |
JP2020518593A (ja) | 皮膚及び/又は粘膜の硬さを増大させるためのネフェリウム・ラッパセウム(Nephelium lappaceum)抽出物の使用 | |
CN111148506A (zh) | 在化妆品和/或营养保健品中使用Let-7b抑制剂的方法 | |
JP7289833B2 (ja) | 植物ゾウゲ抽出物(ファイテレファス属種(Phytelephas sp.))の化粧的使用 | |
CN109350576B (zh) | 具有补水保湿功效的组合物及其应用、化妆水及其制备方法 | |
CN118304226A (zh) | 一种含有金花茶提取物的屏障修护组合物及其制备方法和应用 | |
FR2928549A1 (fr) | Utilisation d'un extrait de l'orchidee brassocattleya marcella koss en tant qu'actif pour prevenir ou retarder l'apparition des signes du vieillissement cutane | |
KR102403451B1 (ko) | 펩타이드 복합체 및 천연 복합 추출물을 함유하는 다기능성 화장료 조성물 | |
KR20210019437A (ko) | 빅사 오렐라나 추출물의 용도 | |
KR20200026112A (ko) | 피키아 아노말라 및 n-아세틸 글루코사민을 포함하는 국소 조성물 | |
KR102382002B1 (ko) | 펩타이드 복합체 및 천연 성분을 함유하는 주름 및 피부탄력 개선, 타이로시네이즈 억제 등 다기능성 화장료 조성물 | |
WO2020008117A1 (fr) | Utilisation cosmetique de hrgp (hydroxyprolin rich glycoproteins) issues de cellules d'ajuga reptans pour prevenir et/ou lutter contre les effets du vieillissement de la peau | |
WO2013188774A2 (en) | Skin care formulations including octapeptide complexes and methods for their manufacture | |
EP1009378A1 (fr) | Utilisations d'extraits de la plante rhoeo discolor dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie | |
CN107823067A (zh) | 一种美白保湿组合物及含有该组合物的护肤品 | |
FR3019043A1 (fr) | Utilisation cosmetique d'un extrait de crambe maritima |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20211022 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220824 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220920 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20221220 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230210 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230320 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230404 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230425 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230516 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230531 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7289833 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |